PTP
TXMD icon

Platform Technology Partners’s TherapeuticsMD TXMD Stock Holding History

Platform Technology Partners’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,400
Closed -$27K – 218
2022
Q1 		$27K Hold
1,400
– – 0.01% 211
2021
Q4 		$25K Sell
1,400
-600
-30% -$18K 0.01% 221
2021
Q3 		$74K Buy
2,000
+1,200
+150% +$53.3K 0.03% 217
2021
Q2 		$48K Buy
+800
New +$48.5K 0.02% 254
2020
Q4 		$48K Sell
800
-100
-11% -$6.83K 0.02% 229
2020
Q3 		$71K Hold
900
– – 0.04% 192
2020
Q2 		$56K Buy
900
+100
+13% +$5.82K 0.04% 192
2020
Q1 		$42K Buy
800
+240
+43% +$23.8K 0.04% 168
2019
Q4 		$68K Buy
+560
New +$80.5K 0.05% 174

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Platform Technology Partners's TXMD Position: Q2 2022 in Review

Platform Technology Partners sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 1,400 shares — an estimated $27K sold.

Platform Technology Partners first reported a position in TXMD in Q4 2019 and held it in 9 quarters. The position peaked at $74K in Q3 2021. 52 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

  • Platform Technology Partners reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
  • Platform Technology Partners sold 1,400 TherapeuticsMD shares in Q2 2022, an estimated $27K.
  • Platform Technology Partners first reported a position in TherapeuticsMD in Q4 2019 and held it in 9 quarters.
  • Platform Technology Partners's TherapeuticsMD position peaked at $74K in Q3 2021.
  • 52 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on Platform Technology Partners's 13F filing for Q2 2022, filed 4 Aug 2022.